Tagore's Day' celebrated at St Aloysius College

Bengaluru, May 25: Heavy rain accompanied by strong winds that lashed Bengaluru last evening left hundreds of trees uprooted near the BTM layout and other areas.

The India Meteorological Department (IMD) has predicted a thunderstorm accompanied with lightning in Karnataka for the next five days.

"Thunderstorm accompanied with lightning at will prevail at isolated places over Gangetic West Bengal, Odisha, Coastal Andhra Pradesh and Yanam, South Interior Karnataka, Kerala and Mahe and Tamilnadu, Puducherry and Karaikal," the IMD said its All Indian Weather Forecast Bulletin.

According to the forecasting agency, due to strong southerly wind from the Bay of Bengal to northeast India at lower tropospheric levels, heavy to very heavy rainfall with extremely heavy falls likely at isolated places over parts of northeastern states.

In addition to that heavy to very heavy rainfall at isolated places over adjoining parts of east India during 24th-28th. "Heavy rainfall at isolated places over parts south peninsular India from May 26th-28th, 2020," the IMD said its All Indian Weather Forecast Bulletin.

Bengaluru, Apr 16: Karnataka Chief Minister BS Yediyurappa on Thursday inaugurated a mobile Covid-19 testing booth in Bengaluru.

These mobile booths will be used in all wards of Bengaluru to collect samples of those suspected to be infected.

According to information available on the website of Ministry of Health and Family Welfare, as of Thursday, 4:00 PM, 279 coronavirus cases have been reported from the state, with 80 cured/discharged/migrated and 12 deaths.

India's coronavirus tally is at 12,380 cases, said the Union Ministry of Health and Family Welfare on Thursday.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.